BCH Biosafety Clearing-House

CBD /

BCH
Search

Search

TAKE SEARCH TOUR

Loading...

This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.

Click here to view the deleted record

This document has been updated. This is not the latest published version. Click here to view the latest version of the record.

Comparing version with latest version

()

|

| PDF | Print |

| Close

Commercial Release of the Biotech Vac COX vaccine, derived from Genetically Modified Microorganism (MGM) - Technical Opinion No. 8962/2024.

Biotech Vac COX vaccine

Country's Decision or any other Communication
Brazil
bch-dec-br-294442-1
Approval of the import and/or use of the LMO(s) without conditions
29 Apr 2026